Next |
home / stock / inab / inab message board
Subject | By | Source | When |
---|---|---|---|
$INAB is it bear time? Or do we go bull? | Invest-in-America | investorshub | 05/11/2023 9:36:13 AM |
The gaining | Invest-in-America | investorshub | 05/04/2023 10:28:25 PM |
and the shorts continue | surf1944 | investorshub | 05/01/2023 7:10:58 AM |
$INAB The now | Hercules1 | investorshub | 04/30/2023 6:15:42 AM |
$INAB great article | Awl416 | investorshub | 04/29/2023 3:31:59 PM |
$INAB best news of the day | Hercules1 | investorshub | 04/29/2023 6:56:13 AM |
bears and bulls | TheFinalCD | investorshub | 04/27/2023 5:49:23 PM |
Uh oh Shorts Im trouble. | Jess070283 | investorshub | 04/26/2023 3:51:28 PM |
Real DUMBASS move by the company this mornings | trendzone | investorshub | 04/26/2023 2:06:47 PM |
Loading this dip for the rip | Jess070283 | investorshub | 04/26/2023 1:37:25 PM |
$INAB: It is CUTE!! (Hey, Boss,$ PBLA & | Invest-in-America | investorshub | 04/26/2023 1:18:35 PM |
Update: IN8bio's INB-400, INB-410 Secure US FDA's Orphan | TheFinalCD | investorshub | 04/26/2023 11:01:26 AM |
Love your scanner! :) | subslover | investorshub | 04/26/2023 10:10:20 AM |
Did they just post same Orphan Drug news | 2020Benzo | investorshub | 04/26/2023 2:02:37 AM |
sub $2 | TheFinalCD | investorshub | 04/25/2023 6:57:30 PM |
https://stockcharts.com/h-sc/ui?s=inab&p=D&yr=0&mn=6&dy=0&id=p38090673899 htt | surf1944 | investorshub | 04/25/2023 11:52:22 AM |
Time to take some profits | ringo1 | investorshub | 04/24/2023 10:33:17 PM |
It hit $3.95. $4 break is coming. $5 quite possible today. | Hercules1 | investorshub | 04/24/2023 5:58:11 PM |
Total beast. Next stop $4. And then $5. | Hercules1 | investorshub | 04/24/2023 5:34:00 PM |
Impressive day | Awl416 | investorshub | 04/24/2023 5:25:21 PM |
News, Short Squeeze, Breakout and More Instantly...
IN8bio Inc. Company Name:
INAB Stock Symbol:
NASDAQ Market:
NEW YORK, May 14, 2024 (GLOBE NEWSWIRE) -- IN8bio, Inc. (NASDAQ:INAB) a clinical-stage biopharmaceutical company developing innovative gamma-de...
NEW YORK, May 14, 2024 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB) a clinical-stage biopharmaceutical company developing innovative gamma-delta T cell therapies, announced today a presentation at the European Hematology Association 2024 Congress, to be held June 13-16 in Madrid, Spain...
NEW YORK, May 13, 2024 (GLOBE NEWSWIRE) -- IN8bio (Nasdaq: INAB), a clinical-stage biopharmaceutical company advancing innovative gamma-delta T cell therapies, presented in an oral session details about its robust and reproducible proprietary clinical-scale gamma-delta T cell manufacturing pl...